Pharmaceutical companies cut production and supply by 60%, officials threatened to monitor exports
AstraZeneca, a British pharmaceutical company, recently reduced the vaccine supply to the European Union by 60% in the first quarter of this year from 80 million doses to 31 million doses in response to the decline in the production capacity of a new crown vaccine factory, which aroused strong dissatisfaction from the European Union. European Commission President Frederick von draen insisted yesterday that pharmaceutical manufacturers must deliver vaccines in accordance with the contract, and Latvian warned that EU Member States would consider filing a complaint if AstraZeneca failed to fulfill the contract. EU health commissioner Kiriya gides issued a statement the day before yesterday, deeply disappointed at the reduction of vaccine supply by AstraZeneca, revealing that the EU plans to set up a “transparent mechanism for vaccine export”, requiring pharmaceutical manufacturers producing in EU countries to export vaccines to non EU countries to make declaration, so as to ensure the vaccine supply in EU.
The EU plans to vaccinate a total of 70% of adult residents in its member states by August. However, the progress of vaccination in the EU is far behind the target. The vaccination rate is less than 2%, lagging behind countries such as the United Kingdom and the United States. After AstraZeneca informed the European Union to reduce the supply of vaccines, van der lain had an emergency telephone call with AstraZeneca chief executive soliott the day before yesterday. Representatives of 27 EU Member States also met with AstraZeneca senior officials to discuss the supply of vaccines. It is reported that at the meeting, AstraZeneca agreed to start the delivery of vaccines to the European Union one week earlier than the original date, and increased the supply of vaccines to the European Union next month, but did not disclose the delivery arrangement in March. Some EU officials asked srikon to transport the vaccine produced in the UK to the EU, but the pharmaceutical factory did not respond.
Kyriagides criticized after the meeting that AstraZeneca’s explanation for reducing supply was not satisfactory, which was unacceptable to the European Union. He proposed to set up a “transparent mechanism for vaccine export” to ensure vaccine supply. At that time, in addition to humanitarian assistance, major pharmaceutical companies will have to declare to the EU if they export any vaccines produced in EU factories to non EU countries. The EU will also take all feasible measures to protect the rights and interests of the people of its member states.
25.3 billion in advance & lt; looking forward to & lsquo; justice & gt; return & gt;
Kyriagides also stressed that the European Union has ordered 300 million doses of AstraZeneca vaccine, and provided a total of 2.7 billion euros (about 25.36 billion Hong Kong dollars) to major pharmaceutical manufacturers to assist in vaccine research and development, hoping that these advances will be & quot; rewarded & quot;. She pointed out that only when the EU has a clear understanding of all the vaccine production and delivery arrangements of AstraZeneca so far can it confirm that the pharmaceutical manufacturers have complied with the contract requirements and provided the EU with “fair and equitable service”;.
The European Drug Administration (EMA) will approve the emergency use of the AstraZeneca vaccine in the European Union on Friday. A spokesman for van der lain said that van der lain stressed to soliott that the European Union has provided a large amount of investment in the research and development of AstraZeneca vaccine to ensure that pharmaceutical manufacturers can increase production before their R & D vaccine is approved by EMA. The EU hopes that AstraZeneca will solve the production problem as soon as possible and deliver the vaccine in accordance with the contract. AstraZeneca did not directly respond to the demand for increased production, but only said that pharmaceutical companies would strengthen cooperation with the European Union to provide vaccines to the European people as soon as possible.
Pfizer’s traffic reduction and Italy’s threat to control
After the EU issued its criticism, many member states responded one after another. The European Union needs to monitor vaccine production and distribution to ensure fair distribution, German Health Minister Stephen Spang said. Latvian Foreign Minister Viktor linkovic said yesterday that the European Union would not rule out suing AstraZeneca for breach of contract. Italy, which earlier threatened to sue Pfizer of the United States for reducing the volume of vaccine shipment, also formally informed Pfizer the day before yesterday that it needed to fulfill the contract, warning that if Pfizer did not respond within a week, Italy would not rule out cooperating with other European countries to take further action.